This financial success underscores radioligand therapeutics' immense commercial and therapeutic potential, signalling their emergence as a pillar of modern oncology. With proof-of-concept ...

These patterns not only inflate expenditures but also disrupt the carefully calibrated treatment schedules that characterize modern oncology practice. Delays in chemotherapy or radiation—whether ...

Larger species face higher cancer risks but those that reached that size rapidly evolved mitigating mechanisms.